Therapeutic medications against diabetes: What we have and what we expect

被引:50
|
作者
Hu, Cheng [1 ,2 ]
Jia, Weiping [1 ]
机构
[1] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai Key Clin Ctr Metab Dis, Shanghai Diabet Inst,Shanghai Key Lab Diabet Mell, 600 Yishan Rd, Shanghai 200233, Peoples R China
[2] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, South Campus,6600 Nanfeng Rd, Shanghai 200433, Peoples R China
基金
中国国家自然科学基金;
关键词
Diabetes; Treatment; Drug delivery; Natural product; GLUCAGON-LIKE PEPTIDE-1; COTRANSPORTER; 2; INHIBITORS; ENCAPSULATES SUBCUTANEOUS IMPLANTS; INADEQUATE GLYCEMIC CONTROL; CARDIOVASCULAR RISK-FACTORS; BLOOD-GLUCOSE CONCENTRATION; GLP-1 RECEPTOR AGONISTS; BETA-CELL FUNCTION; ORAL DELIVERY; INSULIN DELIVERY;
D O I
10.1016/j.addr.2018.11.008
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Diabetes has become one of the largest global health and economic burdens, with its increased prevalence and high complication ratio. Stable and satisfactory blood glucose control are vital to reduce diabetes-related complications. Therefore, continuous attempts have been made in antidiabetic drugs, treatment routes, and traditional Chinese medicine to achieve better disease control. New antidiabetic drugs and appropriate combinations of these drugs have increased diabetes control significantly. Besides, novel treatment routes including oral antidiabetic peptide delivery, nanocarrier delivery system, implantable drug delivery system are also pivotal for diabetes control, with its greater efficiency, increased bioavailability, decreased toxicity and reduced dosing frequency. Among these new routes, nanotechnology, artificial pancreas and islet cell implantation have shown great potential in diabetes therapy. Traditional Chinese medicine also offer new options for diabetes treatment. Our paper aim to overview these therapeutic methods for diabetes therapy. Proper combinations of these existing anti diabetic medications and searching for novel routes are both necessary for better diabetes control. (C) 2018 Published by Elsevier B.V.
引用
收藏
页码:3 / 15
页数:13
相关论文
共 50 条
  • [11] 44 YEARS OF PROFICIENCY TESTING - WHAT WE HAVE ACCOMPLISHED AND WHAT WE EXPECT TO ACCOMPLISH
    LAESSIG, RH
    CLINICAL CHEMISTRY, 1990, 36 (06) : 939 - 939
  • [12] What we have learned and what to expect from capsule endoscopy
    Adler, Samuel N.
    Bjarnason, Ingvar
    WORLD JOURNAL OF GASTROINTESTINAL ENDOSCOPY, 2012, 4 (10): : 448 - 452
  • [13] Antifungals: what we have, what we will have, what we want
    Martinez-Mendez, Dilia
    Bravo-Acosta, Mariolga
    Semprun-Hernandez, Neomar
    INVESTIGACION CLINICA, 2023, 64 (04): : 539 - 556
  • [14] WHAT WE EXPECT AINT ALWAYS WHAT WE GET
    GELLEN, MI
    HOFFMAN, RA
    EDUCATION, 1984, 104 (03): : 264 - 267
  • [15] The Physics and Radiochemistry of Solar Neutrino Detectors: What Have We Learned and What Can We Expect?
    R. L. Hahn
    Journal of Radioanalytical and Nuclear Chemistry, 2000, 243 : 93 - 107
  • [16] Oncology Drug Shortages-What We Have Versus What We Expect to Have? A Critical Scenario of Pakistan
    Elahi, Ehsan
    Andleeb, Sidrah
    JOURNAL OF PHARMACY TECHNOLOGY, 2019, 35 (01) : 41 - 42
  • [17] The physics and radiochemistry of solar neutrino detectors: What have we learned and what can we expect?
    Hahn, RL
    JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY, 2000, 243 (01) : 93 - 107
  • [18] Pneumococcal vaccination: what have we learnt so far and what can we expect in the future?
    A. Torres
    P. Bonanni
    W. Hryniewicz
    M. Moutschen
    R. R. Reinert
    T. Welte
    European Journal of Clinical Microbiology & Infectious Diseases, 2015, 34 : 19 - 31
  • [19] Pneumococcal vaccination: what have we learnt so far and what can we expect in the future?
    Torres, A.
    Bonanni, P.
    Hryniewicz, W.
    Moutschen, M.
    Reinert, R. R.
    Welte, T.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2015, 34 (01) : 19 - 31
  • [20] WE HAVE WHAT WE HAVE
    Krupyna, V
    AB IMPERIO-STUDIES OF NEW IMPERIAL HISTORY AND NATIONALISM IN THE POST-SOVIET SPACE, 2016, (03): : 392 - 399